Skip to main content
SIU School of Medicine Logo

Domain Menu

  • Patient Care
  • School of Medicine

Main Menu Edu Secondary

  • faculty
  • intranet
  • library
  • news & events
  • donate
  • careers
I am a...
  • Patient
  • Donor or Friend
  • Prospective Employee
  • Student/Prospective Student
  • Resident or Fellow
  • Alumni

Main Menu Edu

Main Menu Close
Main Menu
  • Degree Programs
  • Research
  • Academic & Clinical Departments
  • Centers & Institutes
  • Community Programs
    • Equity, Diversity and Inclusion
    • External Relations
    • Family and Community Medicine
    • Office of Community Care
    • Office of Correctional Medicine
    • Population Science and Policy
    • Rural Health and Social Service Development
  • About Us
    • Administrative offices
    • Careers
    • Why SIU School of Medicine
      • Strategic plan
      • A Model for Medical Education
      • Facts and figures
      • Our campuses
    • Economic Impact Report (pdf)
    • History
      • Notable alumni
      • Points of pride
      • Timeline
    • Leadership
      • SIU Medicine Board of Directors
      • SIU School of Medicine Leadership
    • News and Events
Search Site close Close

Breadcrumb

  1. Home
  2. Search

Search Results

search
Reset

Filter Results

By Type

  • Condition (1)
  • Departments (100)
  • Events (208)
  • General Results (2191)
  • Lab (6)
  • Locations (71)
  • Medical Services (12)
  • News (1349)
  • Profiles (1268)
  • Trial (47)
Reset

Filter Results

By Type

  • Condition (1)
  • Departments (100)
  • Events (208)
  • General Results (2191)
  • Lab (6)
  • Locations (71)
  • Medical Services (12)
  • News (1349)
  • Profiles (1268)
  • Trial (47)
Showing: 5253 Results
search
Trial
Urology

A Randomized Open-Label Phase 2/3 Study of BT8009 Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Active recruiting

The main objective of the study is to measure how safe and effective BT8009 (zelenectide pevedotin) is when used alone and in combination with pembrolizumab in participants with locally advanced or metastatic urothelial cancer (UC).

Contact: Kathy Robinson phone217-545-1946 emailsciresearchbc@siumed.edu
News

A Rare Case of Refractory Torsades De Pointes with Diphenhydramine Overdose

Internal Medicine Publications A Rare Case of Refractory Torsades De Pointes with Diphenhydramine Overdose Authors: Bhadari B, Garcia OL, Ibrahim A, & Kulkarni A. (2019) Journal of the American College of Cardiology, 73(9), 2796. http://www.onlinejacc.org/content/73/9_Supplement_1/2796
News

A Rare Case of Refractory Torsades De Pointes With Diphenhydramine Overdose

Internal Medicine Presentations "A Rare Case of Refractory Torsades De Pointes With Diphenhydramine Overdose" Authors: Bhandari, B, Garcia, OL, Ibrahim, A, Kulkarni, A. Journal of the Amercian College of Cardiology. 2019;73(9):2796. Presented at the ACC Conference, March 16-18, 2019. New Orleans, LA. http://www.onlinejacc.org/content/73/9_Supplement_1/2796
News

A Rare Cause of Shortness of Breath In An Adult: Discrete Subaortic Membrane

Internal Medicine Presentations "A Rare Cause of Shortness of Breath In An Adult: Discrete Subaortic Membrane" Authors: Ibrahim A, Ali M, Al-Akchar M, Kulkarni A, Siddique M. Journal of the American College of Cardiology. March 2019;73(9):2568. http://www.onlinejacc.org/content/73/9_Supplement_1/2568
News

A Registered Dietician's Guide to a Gluten-Free Thanksgiving

This Turkey Day, give thanks for gluten-free alternatives and a little creative thinking. Just because you have celiac disease or non-celiac gluten intolerance doesn’t mean you should have to sacrifice your favorite traditional Thanksgiving meals. SIU Medicine’s Sibyl Cox, a registered dietician specializing in pediatric gastroenterology and nutrition, offers her favorite tips for keeping your tummy content this holiday season: Tip #1: Pass on the stuffed turkeys. Some turkey brines or marinades as well as injections can contain gluten, so making sure the bird is gluten-free is important
Trial
Neurology

A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients with Early Alzheimer’s Disease (BenfoTeam)

Active recruiting

The purpose of this study is to learn more about the safety, effectiveness and tolerability of the study drug called Benfotiamine, to determine whether it delays or slows the progression of the symptoms of early Alzheimer’s disease.

Contact: Stephanie Kohlrus phone217-545-3013 emailskohlrus@siumed.edu
News

A Seat at the Table

In 1975, the first class graduated from the then just five-year-old SIU School of Medicine. To look at the class photo, two things stand out for those of us looking at it with a 2017 gaze: in this small class of 24 people, there is only one person of color, and not one is female. The 1976 class, the charter class of the school, was significantly larger. The class of ’76 saw 43 graduates. Among those 43, there were no minorities, and just five women: Cris Anderson, MD, Brenda Baumann, MD, Regina Kovach, MD, Kathleen Link, MD, and Mary (Witges) Bengtson, MD. The charter women of SIU School of
News

A SMART way to train SIU Residents at the MCLI

The SMART curriculum is a simulation based curriculum used to personalize resident training at SIU's Emergency Medicine residency program.
General Results

A Student's Perspective: Catherine Williams, MP '19

Catherine Williams, D.P.M. is a Doctor of Podiatric Medicine and a Captain in the U.S. Air Force. Read about her experience in MEDPREP, in her own words, below. Greetings, My name is Catherine Sue Williams, a proud native Arkansan, who was born and raised in Little Rock, Arkansas. My passion for medicine commenced when I was eight years old when I lost my father to colon cancer unfortunately. It has since been strengthened through my experiences volunteering in health clinics, shadowing various specialties in medicine, conducting research on Alzheimer’s disease, and much more. After graduating
News

A study in longevity: Dr. Don Caspary earns new 5-year NIH grant

His latest NIH grant marks an incredible 38-year run of federal funding for Dr. Don Caspary’s scientific studies of auditory signaling in the brain.
Go back to search filters

Pagination

  • Previous page ‹‹
  • …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Current page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • …
  • Next page ››

This browser is no longer supported and some key features will not work. We strongly recommend using Edge, Chrome 70+, Safari 5.x+ and Firefox 5.x+.

SIU School of Medicine Logo
© 2025 SIU Board of Trustees all rights reserved

Legal

  • Equal Opportunity Employer
  • Nondiscrimination Statement
  • Privacy Policy
  • FOIA
  • ADA

About Us

  • About Us
  • Contact
  • SIU Intranet
  • SIU Medicine
  • Southern Illinois University Carbondale
  • Southern Illinois University Edwardsville
  • Southern Illinois University System

Social

  • Facebook
  • Twitter
  • Youtube
  • Instagram